- Home
- USPH vs MDXG Comparison
USPH vs MDXG Comparison
Compare USPH & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USPH
- MDXG
- Stock Information
- Founded
- USPH 1990
- MDXG 2006
- Country
- USPH United States
- MDXG United States
- Employees
- USPH N/A
- MDXG N/A
- Industry
- USPH Medical/Nursing Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- USPH Health Care
- MDXG Health Care
- Exchange
- USPH Nasdaq
- MDXG Nasdaq
- Market Cap
- USPH 1.1B
- MDXG 1.2B
- IPO Year
- USPH 1992
- MDXG N/A
- Fundamental
- Price
- USPH $67.45
- MDXG $6.68
- Analyst Decision
- USPH Strong Buy
- MDXG Strong Buy
- Analyst Count
- USPH 4
- MDXG 3
- Target Price
- USPH $109.00
- MDXG $12.00
- AVG Volume (30 Days)
- USPH 131.7K
- MDXG 587.5K
- Earning Date
- USPH 05-06-2025
- MDXG 04-30-2025
- Dividend Yield
- USPH 2.67%
- MDXG N/A
- EPS Growth
- USPH 43.97
- MDXG N/A
- EPS
- USPH 1.84
- MDXG 0.28
- Revenue
- USPH $664,433,000.00
- MDXG $348,879,000.00
- Revenue This Year
- USPH $15.34
- MDXG $10.04
- Revenue Next Year
- USPH $5.91
- MDXG $11.53
- P/E Ratio
- USPH $36.64
- MDXG $23.86
- Revenue Growth
- USPH 10.99
- MDXG 8.52
- 52 Week Low
- USPH $62.77
- MDXG $5.47
- 52 Week High
- USPH $108.14
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- USPH 34.58
- MDXG 32.24
- Support Level
- USPH $62.77
- MDXG $6.55
- Resistance Level
- USPH $72.71
- MDXG $7.34
- Average True Range (ATR)
- USPH 3.47
- MDXG 0.36
- MACD
- USPH 0.34
- MDXG -0.04
- Stochastic Oscillator
- USPH 42.51
- MDXG 15.75
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.